Vertebral Compression Fracture Devices Market to Approach $2B by 2030

Vertebral compression fracture devices are expected to generate quite a bit of profit within the next eight years, as the world’s aging population, increasing numbers of spine disorders, and patients’ penchant for minimally invasive surgery fuels demand for these products.

An Allied Market Research report estimated the sector to be worth $866.7 million in 2020, and predicts it will reach $1.9 billion by 2030, swelling 8.1 percent annually over the next eight years. Reimbursement challenges, however, could hinder the market’s growth, according to the report. 

COVID-19 has taken a considerable toll on the vertebral compression fractures market by impacting demand for the devices. 

North America held the lion’s share of the market in 2020, accounting for nearly three-fifths of the sector. But the Asia-Pacific market is expected to grow the fastest this decade (10.5 percent annually, Allied Market Research data show).

Based on product type, the balloon kyphoplasty segment held the largest market share in 2020, accounting for more than four-fifths of the vertebral compression fracture devices sector. This segment is projected to expand more than others, at 8.5 percent annually.  

On the basis of diseases, the minimally invasive spine surgery segment was dominant in 2020, capturing nearly 90 percent of the market. This segment is expected to experience the most robust growth through 2030 (8.6 percent annually). 
 
The prime vertebral compression fracture devices market players include Alphatec Holdings Inc. Globus Medical Inc., Benvenue Medical, Medtronic plc, Johnson & Johnson (Depuy Synthes), Osseon LLC, Orthovita Inc., VEXIM SA, Stryker Corporation, and Zimmer Biomet Holdings Inc.